CAR-T therapy can be a treatment option for medical tourists or international patients who are seeking medical care outside of their home country. However, accessing CAR-T therapy as a medical tourist can be challenging due to factors such as the high cost of treatment, the need for specialized medical expertise, and the complex logistics of cell therapy manufacturing and delivery.

Some hospitals or clinics that offer CAR-T therapy may accept international patients, but this would typically require patients to navigate the healthcare system and insurance requirements of the country in which the treatment is being administered. Additionally, patients would need to factor in the cost of travel and accommodations, as well as potential language and cultural barriers.

In general, it is recommended that patients seeking CAR-T therapy as medical tourists or international patients work with a medical tourism facilitator or agency that can help them navigate the logistics of accessing treatment abroad. These facilitators can help patients identify hospitals or clinics that offer CAR-T therapy, facilitate communication with medical professionals, and help with travel arrangements and logistics.

However, it is important to note that CAR-T therapy is a highly specialized and personalized treatment, and not all hospitals or clinics may have the expertise or infrastructure to provide this treatment to international patients. Patients should thoroughly research and evaluate their options, and seek input from medical professionals, before pursuing CAR-T therapy as a medical tourist.

CAR-T cell therapy in Israel
CAR-T for Leukemia and Lymphoma in Israel
CAR-T for Myeloma in Israel
CAR-T cell therapy for leukemia and non-Hodgkin's lymphoma (NHL) in Europe
CAR-T cell therapy for Multiple Myeloma patients in Europe